ESMO Clinical Practice Guidelines

Establishing the highest standards of clinical practice is a collective effort of the whole oncology community. The ESMO Clinical Practice Guidelines, prepared and reviewed by leading experts, help you provide patients with the best care options.

Cancer research is constantly advancing. Evidence-based medicine transfers the results of that research into new standards and methods for clinical practice. Thanks to ESMO’s regularly updated Clinical Practice Guidelines the decisions you make every day are supported by the informed consensus of the leading experts in our profession.

ESMO Clinical Practice Guidelines: Breast Cancer

ESO-ESMO Advanced Breast Cancer • Primary Breast Cancer • BRCA in Breast Cancer

view detailsof ESMO Clinical Practice Guidelines: Breast Cancer

ESMO Clinical Practice Guidelines: Cancers of Unknown Primary Site

Cancers of Unknown Primary Site

view detailsof ESMO Clinical Practice Guidelines: Cancers of Unknown Primary Site

ESMO Clinical Practice Guidelines: CNS Malignancies

High-Grade Malignant Glioma

view detailsof ESMO Clinical Practice Guidelines: CNS Malignancies

ESMO Clinical Practice Guidelines: Endocrine Cancers

Adrenal cancer • Thyroid cancer

view detailsof ESMO Clinical Practice Guidelines: Endocrine Cancers

ESMO Clinical Practice Guidelines: Gastrointestinal Cancers

Anal Cancer • Metastatic Colorectal Cancer • Oesophageal Cancer • Gastric Cancer • Early Colon Cancer • Familial Risk Colorectal Cancer • Rectal Cancer • Pancreatic Adenocarcinoma • Hepatocellular Carcinoma • Biliary Cancer

view detailsof ESMO Clinical Practice Guidelines: Gastrointestinal Cancers

ESMO Clinical Practice Guidelines: Genitourinary Cancers

Bladder Cancer • Renal Cell Carcinoma • Prostate Cancer • Penile Carcinoma • Testicular Seminoma and Non-Seminoma

view detailsof ESMO Clinical Practice Guidelines: Genitourinary Cancers

ESMO Clinical Practice Guidelines: Gynaecological Cancers

Endometrial Cancer • Gestational Trophoblastic-Disease • Newly-Diagnosed and Relapsed Epithelial Ovarian Carcinoma • Non-Epithelial Ovarian Cancer

view detailsof ESMO Clinical Practice Guidelines: Gynaecological Cancers

ESMO Clinical Practice Guidelines: Haematological Malignancies

Newly-Diagnosed and Relapsed Mantle Cell Lymphoma • Newly-Diagnosed and Relapsed Follicular Lymphoma • Hodgkin's Lymphoma • Primary Cutaneous Lymphoma • Multiple Myeloma • Acute Myeloblastic Leukaemia in Adult Patients • Waldenstrom's Macroglobulinaemia • Gastric Marginal Zone Lymphoma of MALT Type • Chronic Myeloid Leukemia • Diffuse Large B Cell Lymphoma • Chronic Lymphocytic Leukemia

view detailsof ESMO Clinical Practice Guidelines: Haematological Malignancies

ESMO Clinical Practice Guidelines: Head and Neck Cancers

Nasopharyngeal Cancer • Squamous-Cell Carcinoma of the Head and Neck

view detailsof ESMO Clinical Practice Guidelines: Head and Neck Cancers

ESMO Clinical Practice Guidelines: Lung Cancer

Metastatic Non-Small-Cell Lung Cancer • Early-Stage and Locally Advanced (non metastatic) Non-Small-Cell Lung Cancer • Small-Cell Lung Cancer • Malignant Pleural Mesothelioma

view detailsof ESMO Clinical Practice Guidelines: Lung Cancer

ESMO Clinical Practice Guidelines: Melanoma

Cutaneous Melanoma

view detailsof ESMO Clinical Practice Guidelines: Melanoma

ESMO Clinical Practice Guidelines: Neuroendocrine Tumours

Neuroendocrine Bronchial and Thymic Tumours • Neuroendocrine Gastroenteropancreatic Tumours

view detailsof ESMO Clinical Practice Guidelines: Neuroendocrine Tumours

ESMO Clinical Practice Guidelines: Sarcoma and GIST

Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours

view detailsof ESMO Clinical Practice Guidelines: Sarcoma and GIST

ESMO Clinical Practice Guidelines: Supportive Care

Management of Refractory Symptoms at the End of Life and the Use of Palliative Sedation • Advanced Care Planning • Bone Health in Cancer Patients • Cancer, Pregnancy and Fertility • Management of Chemotherapy Extravasation • Cardiovascular Toxicity Induced Chemotherapy Targeted Agents and Radiotherapy • Management of Cancer Pain • Management of Venous Thromboembolism (VTE) in Cancer Patients • Management of Oral and Gastrointestinal Mucositis • Erythropoiesis Stimulating Agents in the Treatment of Anaemia in Cancer Patients • Prevention of Chemotherapy and Radiotherapy Induced Nausea and Vomiting • Management of Febrile Neutropenia • Haematopoietic Growth Factors

view detailsof ESMO Clinical Practice Guidelines: Supportive Care

ESMO Pocket Guidelines & Mobile App

Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients

view detailsof ESMO Pocket Guidelines & Mobile App